// App-Quantinova.ai

: High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada

Researchers

Presenter

  • Sumit Gupta

Principal Investigators

  • Sarah Alexander

  • Sue Zupanec

  • Uma Athale

  • Mylene Bassal

  • Ethan Edwards

  • Paul J. Gibson

  • Donna Johnston

  • Stacey Marjerrison

  • Alexander Zorzi

  • Johann K. Hitzler

  • Ahmed Naqvi

  • Angela Punnett

  • James A. Whitlock

  • Stephan A. Grupp

  • Shannon L. Maude

  • Joerg Krueger

Medical Centers

  • Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Pediatric Haematology/Oncology, Hospital for Sick Children, Toronto

  • Hospital for Sick Children, Toronto, ON, Canada

  • McMaster Children's Hospital, Division of Pediatric Hematology/Oncology, Hamilton, Canada

  • The Children's Hospital of Eastern Ontario, Ottawa, ON, Canada

  • The Children's Hospital of Eastern Ontario, Ottawa, ON, Canada

  • Children's Hospital, London Health Sciences Centre, London, Canada

  • McMaster Children's Hospital, Hamilton, ON, Canada

  • London Health Sciences Center, London, ON, Canada

  • Hospital for Sick Children, Toronto, ON, Canada

  • Hospital for Sick Children; Univ. Toronto

  • Center for Childhood Cancer Research, Childrens Hospital of Philadelphia, Philadelphia, PA

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Neutropenia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved